celecoxib has been researched along with Gastritis in 9 studies
Gastritis: Inflammation of the GASTRIC MUCOSA, a lesion observed in a number of unrelated disorders.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To see whether celecoxib prevents gastric cancer occurrence by disrupting the progression of chronic gastritis into gastric carcinoma through its inhibition of the migration of CD133-positive cells, one of the surface markers of bone marrow-derived cells, in Helicobacter pylori-infected gerbils." | 3.76 | Celecoxib inhibits CD133-positive cell migration via reduction of CCR2 in Helicobacter pylori-infected Mongolian gerbils. ( Futagami, S; Gudis, K; Hamamoto, T; Horie, A; Kawagoe, T; Nagoya, H; Sakamoto, C; Shimpuku, M; Shindo, T, 2010) |
| " The objective of this study was to evaluate the risk of upper GI adverse events associated with celecoxib and oral and parenteral non-selective NSAIDs in cirrhotic patients." | 1.38 | Non-steroidal anti-inflammatory drugs use and risk of upper gastrointestinal adverse events in cirrhotic patients. ( Chang, CH; Chen, HC; Lai, MS; Lee, YC; Lin, JW; Lin, MS, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (66.67) | 29.6817 |
| 2010's | 3 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ranatunge, RR | 1 |
| Augustyniak, M | 1 |
| Bandarage, UK | 1 |
| Earl, RA | 1 |
| Ellis, JL | 1 |
| Garvey, DS | 1 |
| Janero, DR | 1 |
| Letts, LG | 1 |
| Martino, AM | 1 |
| Murty, MG | 1 |
| Richardson, SK | 1 |
| Schroeder, JD | 1 |
| Shumway, MJ | 1 |
| Tam, SW | 1 |
| Trocha, AM | 1 |
| Young, DV | 1 |
| Gupta, A | 1 |
| Zheng, L | 1 |
| Ramanujam, V | 1 |
| Gallagher, J | 1 |
| Dutta, N | 1 |
| Sarotra, P | 1 |
| Gupta, S | 1 |
| Aggarwal, R | 1 |
| Agnihotri, N | 1 |
| Futagami, S | 1 |
| Hamamoto, T | 1 |
| Shimpuku, M | 1 |
| Nagoya, H | 1 |
| Kawagoe, T | 1 |
| Horie, A | 1 |
| Shindo, T | 1 |
| Gudis, K | 1 |
| Sakamoto, C | 1 |
| Lee, YC | 1 |
| Chang, CH | 1 |
| Lin, JW | 1 |
| Chen, HC | 1 |
| Lin, MS | 1 |
| Lai, MS | 1 |
| Saukkonen, K | 1 |
| Tomasetto, C | 1 |
| Narko, K | 1 |
| Rio, MC | 1 |
| Ristimäki, A | 1 |
| Lugardon, S | 1 |
| Lapeyre-Mestre, M | 1 |
| Montastruc, JL | 1 |
| Moride, Y | 1 |
| Ducruet, T | 1 |
| Boivin, JF | 1 |
| Moore, N | 1 |
| Perreault, S | 1 |
| Zhao, S | 1 |
| Swaak, AJ | 1 |
| Theunissen, DJ | 1 |
9 other studies available for celecoxib and Gastritis
| Article | Year |
|---|---|
Synthesis and selective cyclooxygenase-2 inhibitory activity of a series of novel, nitric oxide donor-containing pyrazoles.
Topics: Administration, Oral; Animals; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cycl | 2004 |
Novel Use of Pharmacogenetic Testing in the Identification of CYP2C9 Polymorphisms Related to NSAID-Induced Gastropathy.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cystitis, Interstitial; Cytochrome P-450 CYP2C9; | 2015 |
Mechanism of action of celecoxib on normal and acid-challenged gastric mucosa.
Topics: Animals; Catalase; Celecoxib; Cyclooxygenase 2 Inhibitors; Gastric Mucosa; Gastritis; Glutathione; G | 2009 |
Celecoxib inhibits CD133-positive cell migration via reduction of CCR2 in Helicobacter pylori-infected Mongolian gerbils.
Topics: AC133 Antigen; Adenocarcinoma; Animals; Antigens, CD; Blotting, Western; Celecoxib; Cell Count; Cell | 2010 |
Non-steroidal anti-inflammatory drugs use and risk of upper gastrointestinal adverse events in cirrhotic patients.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Comorbidity; Cyc | 2012 |
Cyclooxygenase-2 expression and effect of celecoxib in gastric adenomas of trefoil factor 1-deficient mice.
Topics: Adenoma; Angiogenesis Inhibitors; Animals; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; | 2003 |
Upper gastrointestinal adverse drug reactions and cyclo-oxygenase-2 inhibitors (celecoxib and rofecoxib): a case/non-case study from the French Pharmacovigilance Database.
Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Aged; Celecoxib; Cyclooxygenase 2; Cyclo | 2004 |
Prescription channeling of COX-2 inhibitors and traditional nonselective nonsteroidal anti-inflammatory drugs: a population-based case-control study.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Ca | 2005 |
[Safety of specific cyclo-oxygenase 2 inhibitors].
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cost-Benefit Analysis; Cyclooxygenase I | 2001 |